+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Glucose Monitoring Systems Market Report by Component, Demographics, End User, and Region 2024-2032

  • PDF Icon

    Report

  • 138 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5834322
The global continuous glucose monitoring systems market size reached US$ 6.7 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2023-2032.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global continuous glucose monitoring systems market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, demographics and end user.

Breakup by Component:

Sensors
Transmitters and Receivers
Integrated Insulin Pumps

Breakup by Demographics:

Child Population (=14 years)
Adult Population (>14 years)

Breakup by End User:

Clinics and Diagnostics Centers
ICUs
Home Healthcare

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report

1. What was the size of the global continuous glucose monitoring systems market in 2023?
2. What is the expected growth rate of the global continuous glucose monitoring systems market during 2024-2032?
3. What has been the impact of COVID-19 on the global continuous glucose monitoring systems market?
4. What are the key factors driving the global continuous glucose monitoring systems market?
5. What is the breakup of the global continuous glucose monitoring systems market based on the component?
6. What is the breakup of the global continuous glucose monitoring systems market based on the demographics?
7. What is the breakup of the global continuous glucose monitoring systems market based on end user?
8. What are the key regions in the global continuous glucose monitoring systems market?
9. Who are the key players/companies in the global continuous glucose monitoring systems market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Continuous Glucose Monitoring Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Sensors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Transmitters and Receivers
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Integrated Insulin Pumps
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Demographics
7.1 Child Population (=14 years)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Adult Population (>14 years)
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Clinics and Diagnostics Centers
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 ICUs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Home Healthcare
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 A. Menarini Diagnostics S.r.l.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Abbott Laboratories
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 DexCom Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 F. Hoffmann-La Roche AG
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Glysens Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 LifeScan Inc. (Johnson & Johnson)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Medtronic PLC
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtrum Technologies Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Nemaura Medical Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Novo Nordisk A/S
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Senseonics Holdings Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 Waveform Technologies Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
List of Figures
Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2023
Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2023
Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2023
Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2023
Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (=14 years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (=14 years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2023
Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million US$), 2024-2032
Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players

Companies Mentioned

  • A. Menarini Diagnostics S.r.l.
  • Abbott Laboratories
  • DexCom Inc.
  • F. Hoffmann-La Roche AG
  • Glysens Incorporated
  • LifeScan Inc. (Johnson & Johnson)
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • Senseonics Holdings Inc.
  • Waveform Technologies Inc.

Methodology

Loading
LOADING...

Table Information